Dr. Tamara T. Rubenzik, MD

Dr. Rubenzik practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Rubenzik's NPI, 1811200652, was assigned on July 21, 2010. Dr. Rubenzik graduated from Jefferson Medical College of Thomas Jefferson University in 2010. Dr. Rubenzik's California license number on file is A119245.

Dr. Rubenzik's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Rubenzik's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Rubenzik is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rubenzik practices. Vendor and product names are available with a free account.

Nephrology is Dr. Rubenzik's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Rubenzik is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rubenzik's licenses on file in 2 states: California and Arizona.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Rubenzik treats.

CMS data shows 792 Medicare services from Dr. Rubenzik across 8 procedure codes in 2024, for 269 Medicare patients. Medicare paid $42,404 for them.

CMS counts 269 Medicare patients who saw Dr. Rubenzik in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 46% are also on Medicaid. Their average risk score is 3.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rubenzik's median patient age at 70, with 42% women.

In 2024, Dr. Rubenzik wrote 1,767 Medicare Part D claims for 267 patients. 75% of them were for generic drugs. CMS names the drug for 1,455 of them, across 37 drugs with 11 or more claims each, at $393,173 in total drug cost. In 2023, CMS named 1,474 claims across 41 drugs.

Dr. Rubenzik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rubenzik as offering telehealth.

Dmand AI links 5 papers to Dr. Rubenzik, published from 2021 to 2023. Dr. Rubenzik's most frequent co-authors are Michael Bouvet, MD, Brandon Todd Perkovich, MBA, MD and Graham Joseph Spurzem, MD.

CMS Open Payments shows 21 general payments to Dr. Rubenzik from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Relypsa, Inc. paid the most, $82.

Dr. Rubenzik graduated from Jefferson Medical College of Thomas Jefferson University in 2010.

Dr. Rubenzik is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.